In patients with exon 3 SNPs, a larger proportion of tumours with high MGMT expression was 89% (eight out of nine) compared to 67% (29 out of 43) without these SNPs (P=0.19, Fisher's test). The gene discussed is MGMT; the disease is neoplasm.